Alamar Biosciences (ALMR) vs NovoCure (NVCR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Alamar Biosciences is the larger company by market cap ($1.80 billion vs $1.66 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALMR | NVCR |
|---|---|---|
| Share price | $25.91 | $14.22 |
| Market cap | $1.80B | $1.66B |
| 1-day change | -6.70% | -3.00% |
| YTD return | — | +9.98% |
| 1-year return | — | -0.91% |
| 5-year return | — | -87.33% |
| EPS (TTM) | $-1.20 | $-1.30 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $655.35M |
| Revenue growth (YoY) | — | +8.28% |
| Net income (latest FY) | — | $-136.23M |
| Gross margin | — | 74.54% |
| Operating margin | — | -23.47% |
| Net margin | — | -20.79% |
| 52-week high | $39.61 | $21.45 |
| 52-week low | $18.85 | $9.82 |
| Distance from 52-week high | -34.59% | -33.71% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +36.63% | +88.89% |
| Average volume | 411.15K | 1.42M |
| Shares outstanding | 69.39M | 116.45M |
| Employees | 286 | 1,605 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Alamar Biosciences in Industrials and NovoCure in Health Care.
About Alamar Biosciences
ALMR stock →Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
Industrials · Biotechnology: Laboratory Analytical Instruments · 286 employees
About NovoCure
NVCR stock →NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax.
Health Care · Medical/Dental Instruments · 1,605 employees
ALMR vs NVCR FAQ
Which is bigger, Alamar Biosciences or NovoCure?
Alamar Biosciences (ALMR) is larger, with a market capitalization of $1.80B compared with $1.66B for NovoCure (NVCR).
Are Alamar Biosciences and NovoCure in the same industry?
No. Alamar Biosciences is in the Industrials sector, while NovoCure is in Health Care.